AutoGenomics Inc. Company Profile
AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine.
News Articles
Microarray and genomics company AutoGenomics Inc. (Carlsbad, Calif.) refiled for an IPO and hopes to raise up to $65 million. Leerink; Stephens; Mizuho Securities; and Cantor Fitzgerald are underwrite...
Microarray and genomics company AutoGenomics Inc. (Vista, Calif.) amended its IPO and now plans to sell 6 million shares at $9-$11. A $10 price would raise $60 million and value the company at $167.5...
[AutoGenomics] attempts IPO a second time
Molecular diagnostics instrument maker [AutoGenomics Inc.] is making a second attempt to go public on Nasdaq. The company first filed in July 2008 but withdrew the offer last year. This time around Au...
AutoGenomics : IPO for $65 million
AutoGenomics Inc. is again looking to go public, filing plans for an estimated initial public offering of up to $65 million in common stock. The company plans to use its IPO proceeds to expand its sal...
Diagnostics Instrument Maker AutoGenomics Files Again for IPO
AutoGenomics, a Vista, CA-based company that specializes in molecular diagnostics systems, has filed for a $65 million Initial Public Offering (IPO), according to a recent regulatory filing. The compa...
AutoGenomics, a leader in providing automated, molecular microarray testing solutions, announced today that they have received their first Health Canada Medical Device Class III a...
Health Canada approves AutoGenomics’ INFINITI PGx testing system
AutoGenomics, a leader in providing automated, molecular microarray testing solutions, announced today that they have received their first Health Canada Medical Device Class III approvals for their au...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures wi...
AutoGenomics, Inc. and PGXL Labs
AutoGenomics Inc., a privately held company based in Vista, CA, has developed the first automated, microarray-based multiplexing diagnostic platform that can be used to assess dis...
AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platforms that can be used to assess disease signatur...
AutoGenomics, Inc. is one of the first companies to harness the power of genomic and proteomic analysis to develop, manufacture and market a molecular diagnostics solution specifically designed for th...
More Information about "AutoGenomics Inc." on BioPortfolio
We have published hundreds of AutoGenomics Inc. news stories on BioPortfolio along with dozens of AutoGenomics Inc. Clinical Trials and PubMed Articles about AutoGenomics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AutoGenomics Inc. Companies in our database. You can also find out about relevant AutoGenomics Inc. Drugs and Medications on this site too.
